Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor

E-ISSN： 1873-4286|9|19|1499-1528

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.19, 2003-07, pp. : 1499-1528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo

Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-07 ,pp. : 1529-1543

Bentham Science Publishers

Access to resources Recommend Favorite

New developments in the urokinase-type plasminogen activator system

By Rosenberg Steven

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 711-722

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2541-2558

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule inhibitors of urokinase-type plasminogen activator

By Rockway Todd W

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator

Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-07 ,pp. : 1483-1498

Bentham Science Publishers

Access to resources Recommend Favorite